Profil
Sun Kim worked as the Head of Corporate Strategy at Shire Plc from 2018 to 2019, Global Head of Business Service Excellence at Novartis AG from 2015 to 2017, Global Head of Strategy at Alcon Laboratories, Inc. from 2011 to 2013, and Chief Strategy & Investor Relations Officer at Centogene NV from 2019 to 2020.
Dr. Kim received a graduate degree and a doctorate from Stanford University and an undergraduate degree from Seoul National University.
Anciens postes connus de Sun Kim
| Sociétés | Poste | Fin |
|---|---|---|
| CENTOGENE N.V. | Investor Relations Contact | 01/11/2020 |
| SHIRE | Investor Relations Contact | 01/08/2018 |
| NOVARTIS AG | Corporate Officer/Principal | 01/09/2017 |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Corporate Officer/Principal | 01/07/2013 |
Formation de Sun Kim
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Health Technology |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centogene NV
Centogene NV Medical SpecialtiesHealth Technology Provides genetic diagnostic analyses of rare inherited diseases | Health Technology |
















